OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update
Kanika Verma, Malvika Pant, Sarvesh Paliwal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Cardiovascular complications in the Post-Acute COVID-19 syndrome (PACS)
Sheref A. Elseidy, Ahmed K. Awad, Monica Vorla, et al.
IJC Heart & Vasculature (2022) Vol. 40, pp. 101012-101012
Open Access | Times Cited: 68

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
Sukhwinder K. Bhullar, Naranjan S. Dhalla
Cells (2022) Vol. 11, Iss. 21, pp. 3336-3336
Open Access | Times Cited: 50

Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling
Shiju Ye, He Huang, Xue Han, et al.
Circulation Research (2023) Vol. 132, Iss. 6, pp. 707-722
Closed Access | Times Cited: 23

Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 21

S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15

Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension
Fjodor Bekedam, Marie‐José Goumans, Harm Jan Bogaard, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108389-108389
Open Access | Times Cited: 14

The soluble (pro)renin receptor promotes a preeclampsia-like phenotype both in vitro and in vivo
Lachlan G. Schofield, Sarah J. Delforce, Jennifer C. Pryor, et al.
Hypertension Research (2024) Vol. 47, Iss. 6, pp. 1627-1641
Open Access | Times Cited: 4

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
Vasiliki Tsampasian, Natasha Corballis, Vassilios S. Vassiliou
Current Hypertension Reports (2022) Vol. 24, Iss. 10, pp. 425-433
Open Access | Times Cited: 19

Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure
Naranjan S. Dhalla, Karina Oliveira Mota, Vijayan Elimban, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 856-856
Open Access | Times Cited: 2

Therapeutic potential of reserpine in metabolic syndrome: An evidence based study
Kanika Verma, Sarvesh Paliwal, Swapnil Sharma
Pharmacological Research (2022) Vol. 186, pp. 106531-106531
Closed Access | Times Cited: 11

New insights on mode of action of vasorelaxant activity of simvastatin
Kanika Verma, Rahul Shukla, Jaya Dwivedi, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1279-1288
Closed Access | Times Cited: 6

Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10

One-pot Synthesis of Condensed Azepines
Khushboo Bhardwaj, Shivangi Jaiswal, Annu Bhardwaj, et al.
Current Organic Chemistry (2024) Vol. 28, Iss. 11, pp. 815-829
Closed Access | Times Cited: 1

Renin angiotensin system-induced muscle wasting: putative mechanisms and implications for clinicians
Barış Afşar, Rengin Elsürer Afşar, Yaşar Çalışkan, et al.
Molecular and Cellular Biochemistry (2024)
Open Access | Times Cited: 1

Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease
Marieta Theodorakopoulou, Maria Eleni Alexandrou, Afroditi Boutou, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 3, pp. 397-406
Open Access | Times Cited: 11

Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
Krzysztof Mińczuk, Marta Baranowska‐Kuczko, Anna Krzyżewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6350-6350
Open Access | Times Cited: 7

Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function
Takayuki Matsumoto, Kumiko Taguchi, Tsuneo Kobayashi
Journal of Smooth Muscle Research (2021) Vol. 57, pp. 94-107
Open Access | Times Cited: 10

Targeting the renin angiotensin system for respiratory diseases
Phyllis X.L. Gan, Wupeng Liao, Kira M Linke, et al.
Advances in pharmacology (2023), pp. 111-144
Closed Access | Times Cited: 3

Cadmium induces chondroitin sulfate synthase 1 via protein kinase Cα and elongates chondroitin/dermatan sulfate chains in cultured vascular endothelial cells
Takato Hara, Shogo Matsuura, K. Aikawa, et al.
The Journal of Toxicological Sciences (2023) Vol. 48, Iss. 8, pp. 457-467
Open Access | Times Cited: 3

Resveratrol modulates signalling to inhibit vascular smooth muscle cell proliferation induced by angiotensin II and high glucose
A. Türker ÇETİN, Mustafa Kırça, Akın Yeşilkaya
Turkish Journal of Biochemistry (2024) Vol. 49, Iss. 3, pp. 455-462
Open Access

The role of p130Cas/BCAR1 adaptor protein in the pathogenesis of cardiovascular diseases: A literature review
Ghazal Ghasempour Dabaghi, Mehrdad Rabiee Rad, Reza Amani‐Beni, et al.
American Heart Journal Plus Cardiology Research and Practice (2024) Vol. 44, pp. 100416-100416
Open Access

EFFECT OF TISSUE ANGIOTENSINS ON CARDIOVASCULAR SYSTEM ELEMENTS (LECTURE)
Lyudmila O. Gutsol
Baikal Medical Journal (2024) Vol. 3, Iss. 2, pp. 71-81
Open Access

The effect of pre-hospital use of RAS inhibitors on COVID-19 mortality
Rama Ibrahim
Journal of Investigative Medicine (2024) Vol. 72, Iss. 8, pp. 863-875
Closed Access

Page 1 - Next Page

Scroll to top